Multiple protections, worry free coughing and wheezing. By using proprietary antigen epitope peptide adjuvant technology, the body can be induced to produce triple immunity, providing more comprehensive protection.

1. High antigen content: low strain generation, better immunogenicity, and a minimum of 1 × 10 ^ 8 CUU of pre inactivated Mycoplasma per milliliter of vaccine.

2. Exclusive antigen epitope peptide adjuvant technology: a. It can induce the body to produce triple immunity, providing more comprehensive protection: cellular immunity, humoral immunity, and mucosal immunity; b. Improve the cross protection of vaccines against different strains; c. It can provide good cross protection for PCV-2, PCV-3, and HPS1/4/5/7 simultaneously (one needle multiple protection).

3. BEI inactivation method: fully preserves the surface antigen characteristics of mycoplasma, better generates immune response, and the degradation products are non irritating to the body.

4. Improving daily weight gain: After vaccination, the average daily weight gain per pig can be increased by 25-43g.

5. Reduce the number of days on the market: after vaccination, due to the decline in the incidence rate of pigs, the average weight of pigs on the market will be 5-10 days earlier.

Usage and dosage:Recommended immunization program (intramuscular injection): Newborn piglets should be vaccinated with 1ml per piglet for the first 2-3 weeks, and strengthened with 2ml per piglet every 3 weeks; The breeding pig herd should be vaccinated with 2ml/head every 4 months; Immunization twice before mating of the reserve group, with an interval of 3-4 weeks, 2ml/head.

Specification packaging:20ml x 10 bottles/box